๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ultrasound degradation of novel polymer contrast agents

โœ Scribed by El-Sherif, Dalia M. ;Lathia, Justin D. ;Le, Ngocyen T. ;Wheatley, Margaret A.


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
204 KB
Volume
68A
Category
Article
ISSN
0021-9304

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

This report describes an investigation into factors affecting the degradation of novel poly(lacticโ€coโ€glycolic acid) (PLGA) contrast agents. Contrast agents fabricated by two different methods and varying in acoustic properties were compared. The effect of ultrasound frequency (5 and 10 MHz) on degradation of the microcapsules was also studied. Highโ€performance liquid chromatography was used to quantify the production of lactic and glycolic acid to monitor agent degradation. The degradation pattern from the microcapsules was found to be closely related to capsule morphology; the more acoustically efficient capsules (maximum enhancement of 25 dB at 5 MHz with 0.004 mg/mL) degraded at a faster rate than those with lower acoustical efficiency (maximum enhancement of 25 dB at 5 MHz only achieved with 0.6 mg/mL). The capsules also degraded fastest when insonated at the frequency at which they gave highest backscatter. In addition, despite the use of a 50:50 PLGA copolymer, more glycolic than lactic acid was released at early time points, which reflects the greater hydrophilicity of the glycolic acid residues, and greater degradation rate of glycolic acid repeat units. The results from this study provided unique insight into the degradation behavior of hollow PLGA microcapsules, and their potential in ultrasound diagnosis and therapy. ยฉ 2003 Wiley Periodicals, Inc. J Biomed Mater Res 68A: 71โ€“78, 2004


๐Ÿ“œ SIMILAR VOLUMES


Targeted binding of PEG-lipid modified p
โœ Wynter J. Duncanson; Kelleny Oum; John R. Eisenbrey; Robin O. Cleveland; Margare ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 417 KB ๐Ÿ‘ 1 views

## Abstract In order for siteโ€directed polymer ultrasound contrast agents (UCAs) to provide acoustic enhancement at disease sites to distinguish normal tissue from diseased tissue, the surface of these agents must be functionalized with mixtures of grafted polymers. Here a combination of longer lig

Development of a novel method for synthe
โœ El-Sherif, Dalia M. ;Wheatley, Margaret A. ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 256 KB

## Abstract Medical ultrasound is a highly valuable diagnostic tool, especially when compared with other imaging modalities. It is a noninvasive, realโ€time, portable, extremely safe method compared with Xโ€ray and inexpensive relative to magnetic resonance imaging. However, ultrasound is limited in

Color Doppler ultrasound of liver lesion
โœ Ernst, H.; Hahn, E. G.; Balzer, T.; Schlief, R.; Heyder, N. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 618 KB

Patients with focal liver lesions (hemangioma, focal nodular hyperplasia, adenoma, hepatocellular carcinoma, metastatic lesions, focal fatty lesion) received the ultrasound contrast agent Levovista (300 mglmL and 400 mg/mL) intravenously. This ultrasound contrast agent (a suspension of micrometer-si